Sharma East India Hospitals & Medical Research Share Price
96.00+0.50 (+0.52%)
-58.12% past 1 Year
Sharma East India Hospitals & Medical Research Ltd was incorporated in 1989. They are engaged in providing services in the field of medical science. They are located in Jaipur Rajasthan.
Corporate filings & documents
Announcements
Newspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
3 weeks agoNewspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
3 weeks agoapproval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
3 weeks agoapproval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
3 weeks agoApproval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.
3 weeks agoApproval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.
3 weeks agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
1 month agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
1 month agoCertificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30-06-2026.
1 month agoCertificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30-06-2026.
1 month agoIntimation of closure of trading window for the quarter ended June 30 2026.
2 months agoIntimation of closure of trading window for the quarter ended June 30 2026.
2 months agoThe Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
3 months agoThe Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
3 months agoas per attachment
3 months agoApproval of audited financial results for the quarter and year ended 31st March 2026
3 months agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31 2026 pursuant to regulation 33 of SEBI (LODR) Regulation 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
3 months agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31 2026 pursuant to regulation 33 of SEBI (LODR) Regulation 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sharma East India Hospitals & Medical Research Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110RJ1989PLC005206</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Ms Bhawana Sharma <br/> Designation: Company Secretary cum compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vimal Kumar Joshi <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sharma East India Hospitals & Medical Research Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110RJ1989PLC005206</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Ms Bhawana Sharma <br/> Designation: Company Secretary cum compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vimal Kumar Joshi <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agocompliances certificate under Reg74(5) of SEBI(DP) Regulations 2018 for the quarter ended ended 31-03-2026.
4 months agointimation for closure of trading Window
5 months agoAs per attachment.
6 months agoapproval of unaudited financial results for the quarter ended December 31 2025.
6 months agoapproval of unaudited financial results for the quarter ended December 31 2025.
6 months agoApproval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015 along with limited review report.
6 months agoApproval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015 along with limited review report.
6 months agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 31st December 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director
7 months agoCompliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025
7 months agoIntimation For Closure Of Trading Window For Quarter ended 31st Dec 2025.
8 months agoAs per attachment
9 months agoResignation of Independent non-executive Director of the Company.
9 months agoAs per attachment.
9 months agoAs per attachment.
9 months agoSharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th September 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
10 months agoCompliances certificate under regulation 74(5) of SEBI (DP_ Regulations 2018 for the qtr ended 30-09-2025.
10 months agoVoting results and scrutinizer report for the annual geneal meeting held on 30-09-2025.
11 months agoProceeding of 36th Annual Genreal Meeting held on 30th September 2025
11 months agoIntimation of closer of Trading window
11 months agoAs per attachment.
11 months ago36th Annual Report for the Financial Year 2024 - 2025 pursuant to Compliance as per regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements [LODR]) Regulations 2015.
12 months agoNotice of 36th AGM
12 months agoAs per attachement
12 months agoas per attachement
12 months agoNotice of book closure for the purpose of annual general meetign to be held on September 30 2025
12 months agoRe-appoinment of Managing Director of the compny subject to approval of shareolders of the company at the ensuing annual general Meeting.
12 months agoAs per attachment.
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Jaipur Hospital Near Sms Stadium Lal Kothi, Tonk Road Jaipur Rajasthan PIN: 302015 Tel No: 0141 2742557 / 2742266 Fax No: 0141-2742472 Email: [email protected] Internet: www.jaipurhospital.co.in
Registrars
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL
Management
Bhawana Sharma, Company Secretary & Compliance Officer
Shailendra Kumar Sharma, Managing Director
Karan Sharma, Non Executive Director
Maya Sharma, Non Executive Director
Pushpendra Prasad Garg, Non Executive Independent Director
Pawan shorey, Non Executive Independent Director
Srikant Vinayakrao Bulakh, Non Executive Independent Director
Radhika Sathe, Non Executive Director
Details
BSE 524548
NSE NULL
ISIN INE465H01012